Real-world evidence of long-term durability and efficacy of faricimab as an advanced treatment line for NVAMD and DME. Galindo AM, Ohayon A, Hod K, Levin MF, et al. Int Ophthalmol 2025;46:47.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Galindo AM, Ohayon A, Hod K, Levin MF, et al. Real-world evidence of long-term durability and efficacy of faricimab as an advanced treatment line for NVAMD and DME. Int Ophthalmol 2025;46:47.
PMID: 41432839